GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (LTS:0LO4) » Definitions » Research & Development

Ventas (LTS:0LO4) Research & Development : $0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Ventas Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Ventas's Research & Development for the three months ended in Sep. 2024 was $0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was $0 Mil.

Ventas Research & Development Historical Data

The historical data trend for Ventas's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ventas Research & Development Chart

Ventas Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ventas Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ventas Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ventas  (LTS:0LO4) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ventas Research & Development Related Terms

Thank you for viewing the detailed overview of Ventas's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Ventas Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Ventas Inc (LTS:0LO4) » Definitions » Research & Development
Comparable Companies
DOC OHI HR CTRE AHR SBRA NHI MPW LTC SILA WELL TSX:CSH.UN XBRU:AED XBRU:COFB SGX:C2PU LSE:PHP LSE:AGR TSX:NWH.UN NZSE:VHP LSE:THRL
Traded in Other Exchanges
VTR:USA VTR:Mexico VEN:Germany VEN:Germany V1TA34:Brazil
Address
353 North Clark Street, Suite 3300, Chicago, IL, USA, 60654
Website
https://www.ventasreit.com
Ventas owns a diversified healthcare portfolio of over 1,300 in-place properties spread across the senior housing, medical office, hospital, life science, and skilled nursing/post-acute care. The portfolio includes almost 100 properties in Canada and the United Kingdom as the company looks for additional investment opportunities in countries with mature healthcare systems that operate similarly to the United States. The firm also owns mortgages and other loans, contributing about 1% of net operating income.

Ventas Headlines

No Headlines